Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors.

ABSTRACT: Pancreatic neuroendocrine neoplasms (panNENs) are heterogeneous neoplasms with neuroendocrine differentiation that show peculiar clinical and histomorphological features, with variable prognosis. In recent years, advances in knowledge regarding the pathophysiology and heterogeneous clinical presentation, as well as the availability of different diagnostic procedures for panNEN diagnosis and novel therapeutic options for patient clinical management, has led to the recognition of the need for an active multidisciplinary discussion for optimal patient care. Molecular imaging with positron emission tomography/computed tomography (PET/CT) has become indispensable for the management of panNENs. Several PET radiopharmaceuticals can be used to characterize either panNEN receptor expression or meta

SUBMITTER: Calabro D 

PROVIDER: S-EPMC7762240 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature